Clinical Trials List
Protocol Number107066 (H5N1-009); 108498 (H5N1-022 STG 009 cohort 2); 108500 (H5N1-023 STG 009 cohort 3)
2007-09-26 - 2008-09-30
Phase II
Terminated2
-
Trial Applicant
GlaxoSmithKline
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
- Luan-Yin Chang Division of Pediatrics
- Chun-yi Lu Division of Pediatrics
The Actual Total Number of Participants Enrolled
0 Stop recruiting
Co-Principal Investigator
- 李文珍 Division of Pediatrics
- 郭貞孍 Division of Pediatrics
- 林本一 Division of Pediatrics
- 段寶蘭 Division of Pediatrics
- Yhu-Chering Huang Division of Pediatrics
- 李浩遠 Division of Pediatrics
- Cheng-Hsun Chiu Division of Pediatrics
- 黃冠穎 Division of Pediatrics
- 梁景祥 Division of Pediatrics
- Chi-Long Chen Division of Pediatrics
The Actual Total Number of Participants Enrolled
0 Stop recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
200 participants
-
Global
400 participants
